In the News

  • May 05, 2021

    What immuno-oncology research can tell us about Covid-19

    Drug Therapy Review  | Jing Watnick

    Read Full Article »

  • August 07, 2020

    The BioSpace interview on Vigeo’s Tumor Microenvironment Platform Expands Indications and Combo Therapy Possibilities | By Gail Dutton

    Read Full Article »

  • March 17, 2020

    Biotech Strategy Blog – Helping more patients respond to immunotherapy (an interview with Sally Church)

    Thoughtful interview by Sally Church and Biotech Strategy Blog with Vigeo CEO Jing Watnick and co-founder Randy Watnick

    Read Full Article »